Analyzing brain wave patterns to find new uses for existing drugs in rare diseases
EEG Signature Analysis for Drug Repurposing for Rare Diseases
This study is looking to find new ways to use existing medications for rare diseases and mental health conditions by analyzing brain wave patterns from animal models, making it easier and cheaper to discover helpful treatments for people like you.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Psychogenics, INC. NIH-funded |
| Lab location | 1 site (Paramus, UNITED STATES) |
| Project ID | NIH-11004734 on NIH RePORTER |
What this research studies
This research focuses on improving drug discovery for rare diseases and psychiatric disorders by utilizing EEG (electroencephalogram) data. The team will develop a platform that analyzes brain wave patterns from animal models of rare diseases to identify potential new uses for existing drugs. By comparing these patterns with a database of known drug signatures, the researchers aim to generate hypotheses for drug repurposing. This approach seeks to reduce the high costs and risks associated with traditional drug development.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with rare diseases or psychiatric disorders who may benefit from new treatment options.
Not a fit: Patients with common diseases or those who do not have access to EEG testing may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more cost-effective treatments for patients with rare diseases.
How similar studies have performed: Previous research has shown promise in drug repurposing using similar algorithmic approaches, indicating potential for success in this novel application.
Where this research is happening
Paramus, UNITED STATES
- Psychogenics, INC. — Paramus, United States (Active)
Researchers
- Principal investigator: Brunner, Daniela — Psychogenics, INC.
- Study coordinator: Brunner, Daniela
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.